Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Mavrilimumab
(D09930)
[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[2] 41, 46 💬
2Mavrilimumab 10 MG
(D09930)
[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
3Mavrilimumab 100 MG
(D09930)
[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
4Mavrilimumab 150 MG
(D09930)
[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
5Mavrilimumab 30 MG
(D09930)
[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬
6Mavrilimumab 50 MG
(D09930)
[1] Mavrilimumab[1] Mavrilimumab (D09930) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 46 💬